Cancer :: Genes associated with cancer drug resistance

Scientists at the National Cancer Institute (NCI), a part of the National Institutes of Health, have created a database of information about a group of genes associated
with multidrug resistance in cancerous tumors. The research, published in the issue of “Cancer Cell”, details the gene expression of a 48-member family of proteins called ABC transporters. The NCI scientists identified associations between expression of individual ABC transporters in cancer cells and resistance to specific drugs.

HIV :: HIV & AIDS – Naturopathic Physicians

HIV :: HIV & AIDS – Naturopathic Physicians

In many countries throughout the world, people are going to naturopathic physicians when faced with a health issue. Unfortunately, where I live in Vancouver, (British Columbia, Canada) the government is planning to cut back the scope of naturopathic medicine by imposing controls on what a naturopathic physician can and cannot do. The B.C. government does not allow naturopathic physicians to have access to medical labs and x-rays or to prescribe medications. The proposed changes include limiting the ability of naturopathic physicians to perform physical exams, diagnose and treat food allergies and place severe restrictions on the medicines ND’s use to treat patients. We must not lose the right of choice and the right to choose!

New Drug for treatment of Alcoholism

FDA approved the drug Campral (acamprosate), for treating alcohol dependent individuals seeking to continue to remain alcohol-free after they have stopped drinking. Campral may not be effective in patients who are actively drinking at the start of treatment, or in patients who abuse other substances in addition to alcohol.

Rare Diseases: New Help for Patients Without Treatments

Years ago, people diagnosed with a rare disease might have found themselves
with little hope for a medical treatment. This changed in 1983 when American Congress
passed the Orphan Drug Act, a law that offered drug companies special
incentives to develop products for treating diseases with fewer than 200,000
patients a year. The inducements include seven-year marketing exclusivity, tax
credit for the product-associated clinical research, research design assistance
by the FDA, and grants of up to $300,000 per year.

Hyperhidrosis :: Botulinum – Botox to treat severe underarm sweating

FDA has approved Botulinum Toxin Type A (Botox) to treat severe underarm sweating known as primary axillary hyperhidrosis that cannot be managed by topical agents such as prescription antiperspirants. Botox has already been approved for several other purposes. Today?s approval allows the product?s manufacturer, Allergan, Inc., Irvine, Calif., to market Botulinum Toxin Type A for this new indication.

Robotic like device for Heart Surgery

The Food and Drug Administration (FDA) cleared the marketing of a robotic-like system to assist in coronary artery by-pass surgery in which there is direct access to the chest using standard open chest technique (sternotomy) or a smaller surgical incision (thoracotomy).

HIV :: HIV/AIDS drugs saved my life!

From the time I was told I had ?six months to live? by an AIDS specialist in 1985, I learned from other people infected with HIV and included supplements and complementary therapies. These kept me healthy and were responsible for allowing me to address health issues, boost my immune system and avoid going on HIV/AIDS medications for over a dozen years.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack